CME Group Inc’s filing revealed that its Director SHEPARD WILLIAM R acquired Company’s shares for reported $60885.0 on Jun 25 ’24. In the deal valued at $195.07 per share,312 shares were bought. As a result of this transaction, SHEPARD WILLIAM R now holds 253,655 shares worth roughly $50.46 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, SHEPARD WILLIAM R bought 14 shares, generating $2,684 in total proceeds. Upon buying the shares at $195.07, the Director now owns 2,348 shares.
Before that, Carey Charles P sold 3,000 shares. CME Group Inc shares valued at $586,320 were divested by the Director at a price of $195.44 per share. As a result of the transaction, Carey Charles P now holds 7,163 shares, worth roughly $1.42 million.
JP Morgan downgraded its CME Group Inc [CME] rating to an Underweight from a a Neutral in a research note published on June 21, 2024; the price target was decreased to $187 from $206. A number of analysts have revised their coverage, including Barclays’s analysts, who decreased its forecast for the stock in early January from “an Overweight” to “an Equal weight”. Goldman also remained covering CME and has decreased its forecast on January 03, 2024 with a “Sell” recommendation from previously “Neutral” rating. BofA Securities revised its rating on September 06, 2023. It rated CME as “a Neutral” which previously was an “an Underperform”.
Price Performance Review of CME
On Monday, CME Group Inc [NASDAQ:CME] saw its stock fall -0.81% to $198.92. Over the last five days, the stock has lost -0.48%. CME Group Inc shares have fallen nearly -5.55% since the year began. Nevertheless, the stocks have risen 2.64% over the past one year. While a 52-week high of $222.63 was reached on 02/29/24, a 52-week low of $190.70 was recorded on 06/18/24. SMA at 50 days reached $200.21, while 200 days put it at $208.82. A total of 1.43 million shares were traded, compared to the trading of 1.26 million shares in the previous session.
Levels Of Support And Resistance For CME Stock
The 24-hour chart illustrates a support level at 197.88, which if violated will result in even more drops to 196.85. On the upside, there is a resistance level at 200.83. A further resistance level may holdings at 202.75. The Relative Strength Index (RSI) on the 14-day chart is 51.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.58, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 40.17%. Stochastics%K at 67.05% indicates the stock is a holding.
The most recent change occurred on June 28, 2023 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $215 price target.
